{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:18:38Z","timestamp":1764181118857,"version":"3.46.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K07204"],"award-info":[{"award-number":["19K07204"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00280-025-04841-1","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T13:35:28Z","timestamp":1763991328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of IL12RB2, RORC, and class II HLA polymorphisms with severe erythema multiforme of regorafenib in Japanese patients with colorectal cancer"],"prefix":"10.1007","volume":"95","author":[{"given":"Geonwoo","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remi","family":"Murase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsumi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroo","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1575-6690","authenticated-orcid":false,"given":"Ken-ichi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"4841_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ctrv.2017.10.011","volume":"62","author":"M Roed Skarderud","year":"2018","unstructured":"Roed Skarderud M, Polk A, Kjeldgaard Vistisen K, Larsen FO, Nielsen DL (2018) Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review. Cancer Treat Rev 62:61\u201373. https:\/\/doi.org\/10.1016\/j.ctrv.2017.10.011","journal-title":"Cancer Treat Rev"},{"issue":"9863","key":"4841_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","volume":"381","author":"A Grothey","year":"2013","unstructured":"Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouch\u00e9 O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz H-J, Goldberg R, Sargent D, Cihon F, Cupit L, Wagner A, Laurent D (2013) Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381(9863):303\u2013312. https:\/\/doi.org\/10.1016\/S0140-6736(12)61900-X","journal-title":"Lancet"},{"issue":"1","key":"4841_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13223-021-00520-x","volume":"17","author":"S Volkers","year":"2021","unstructured":"Volkers S, Meisel C, Terhorst Molawi D, Burbach G, Sch\u00fcrmann D, Suttorp N, Sander L (2021) Clonal expansion of CD4\u2009+\u2009CD8\u2009+\u2009T cells in an adult patient with Mycoplasma pneumoniae-associated erythema multiforme majus. Allergy Asthma Clin Immunol 17(1):17\u201317. https:\/\/doi.org\/10.1186\/s13223-021-00520-x","journal-title":"Allergy Asthma Clin Immunol"},{"key":"4841_CR4","unstructured":"Hafsi W, Badri T (2024) Erythema multiforme. StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470259\/. Accessed 30 May 2025"},{"issue":"2","key":"4841_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/jgf2.29","volume":"18","author":"M Matsunaga","year":"2017","unstructured":"Matsunaga M, Ushijima T, Fukahori M, Tanikawa K, Miwa K (2017) Erythema multiforme induced by regorafenib. J Gen Fam Med 18(2):90\u201391. https:\/\/doi.org\/10.1002\/jgf2.29","journal-title":"J Gen Fam Med"},{"issue":"4","key":"4841_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s13691-019-00376-4","volume":"8","author":"K Tashiro","year":"2019","unstructured":"Tashiro K, Shinto E, Kajiwara Y, Mochizuki S, Okamoto K, Nishizawa A, Satoh T, Kishi Y, Ueno H (2019) Systemic steroid treatment can desensitize the skin reaction due to regorafenib in a recurrence colorectal cancer patient. Int Cancer Conf J 8(4):164\u2013169. https:\/\/doi.org\/10.1007\/s13691-019-00376-4","journal-title":"Int Cancer Conf J"},{"issue":"3","key":"4841_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/cpt.1810","volume":"108","author":"Y Kubota","year":"2020","unstructured":"Kubota Y, Fujita KI, Takahashi T, Sunakawa Y, Ishida H, Hamada K, Ichikawa W, Tsunoda T, Shimada K, Masuo Y, Kato Y, Sasaki Y (2020) Higher systemic exposure to unbound active metabolites of regorafenib is associated with short Progression-Free survival in colorectal cancer patients. Clin Pharmacol Ther 108(3):586\u2013595. https:\/\/doi.org\/10.1002\/cpt.1810","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"4841_CR8","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1111\/cts.13589","volume":"16","author":"KI Fujita","year":"2023","unstructured":"Fujita KI, Matsumoto N, Murase R, Takeshima K, Ishida H, Kubota Y (2023) Associations of HLA-C*01:02 and HLA-B*46:01 with regorafenib-induced erythema multiforme in Japanese patients with metastatic colorectal cancer. Cts - Clin Translational Sci 16(10):1741\u20131747. https:\/\/doi.org\/10.1111\/cts.13589","journal-title":"Cts - Clin Translational Sci"},{"issue":"2","key":"4841_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4103\/0253-7613.178827","volume":"48","author":"GV Badarkhe","year":"2016","unstructured":"Badarkhe GV, Sil A, Bhattacharya S, Nath UK, Das NK (2016) Erythema multiforme due to arsenic trioxide in a case of acute promyelocytic leukemia: A diagnostic challenge. Indian J Pharmacol 48(2):216\u2013218. https:\/\/doi.org\/10.4103\/0253-7613.178827","journal-title":"Indian J Pharmacol"},{"issue":"4","key":"4841_CR10","first-page":"307","volume":"24","author":"M Czarnecka-Operacz","year":"2016","unstructured":"Czarnecka-Operacz M, Jenerowicz D, Szulczynska-Gabor J, Teresiak-Mikolajczak E, Szyfter-Harris J, Bowszyc-Dmochowska M (2016) Vesicular contact reaction May progress into erythema multiforme. Acta Dermatovenerol Croat 24(4):307\u2013309","journal-title":"Acta Dermatovenerol Croat"},{"key":"4841_CR11","doi-asserted-by":"publisher","unstructured":"Chu MT, Chang WC, Pao SC, Hung SI (2023) Delayed drug hypersensitivity reactions: molecular Recognition, genetic Susceptibility, and immune mediators. Biomedicines 11(1). https:\/\/doi.org\/10.3390\/biomedicines11010177","DOI":"10.3390\/biomedicines11010177"},{"issue":"3","key":"4841_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5114\/ceji.2014.45950","volume":"39","author":"Z Akkurt","year":"2014","unstructured":"Akkurt Z, U\u00e7mak D, T\u00fcrkc\u00fc G, Y\u00fcksel H, Yildiz K, Ar\u0131ca M (2014) Expression of interleukin-17 in lesions of erythema multiforme May indicate a role for T helper 17 cells. Cent Eur J Immunol 39(3):370\u2013376. https:\/\/doi.org\/10.5114\/ceji.2014.45950","journal-title":"Cent Eur J Immunol"},{"key":"4841_CR13","doi-asserted-by":"publisher","unstructured":"Quaglino P, Caproni M, Antiga E, Del Bianco E, Osella Abate S, Savoia P, Frezzolini A, Schena D, Marzano A, Volpi W, De Simone C, Parodi A, Fabbri P, Bernengo M (2007) Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology. dermatology 214(4):296\u2013304. https:\/\/doi.org\/10.1159\/000100880","DOI":"10.1159\/000100880"},{"issue":"8","key":"4841_CR14","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/ced.13213","volume":"42","author":"H Morsy","year":"2017","unstructured":"Morsy H, Taha EA, Nigm DA, Shahin R, Youssef EMK (2017) Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome\/toxic epidermal necrolysis drug reaction, and correlation with disease severity. Clin Exp Dermatol 42(8):868\u2013873. https:\/\/doi.org\/10.1111\/ced.13213","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"4841_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/cpt.683","volume":"102","author":"RY Pan","year":"2017","unstructured":"Pan RY, Dao RL, Hung SI, Chung WH (2017) Pharmacogenomic advances in the prediction and prevention of cutaneous idiosyncratic drug reactions. Clin Pharmacol Ther 102(1):86\u201397. https:\/\/doi.org\/10.1002\/cpt.683","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"4841_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00280-024-04649-5","volume":"94","author":"K Ono","year":"2024","unstructured":"Ono K, Murase R, Matsumoto N, Kubota Y, Ishida H, Fujita KI (2024) Association of VEGFA and CCL4L2 polymorphisms with hand-foot skin reaction and survival of regorafenib in Japanese patients with colorectal cancer. Cancer Chemother Pharmacol 94(1):57\u201366","journal-title":"Cancer Chemother Pharmacol"},{"key":"4841_CR17","unstructured":"dbSNP National Center for Biotechnology Information (2025) https:\/\/www.ncbi.nlm.nih.gov\/snp\/. Accessed 30 May"},{"issue":"5","key":"4841_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","volume":"30","author":"L Zhou","year":"2009","unstructured":"Zhou L, Chong MMW, Littman D (2009) Plasticity of CD4\u2009+\u2009T cell lineage differentiation. Immunity 30(5):646\u2013655. https:\/\/doi.org\/10.1016\/j.immuni.2009.05.001","journal-title":"Immunity"},{"issue":"4","key":"4841_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1258\/0007142001903634","volume":"56","author":"A Rao","year":"2000","unstructured":"Rao A, Avni O (2000) Molecular aspects of T-cell differentiation. Br Med Bull 56(4):969\u2013984. https:\/\/doi.org\/10.1258\/0007142001903634","journal-title":"Br Med Bull"},{"issue":"2","key":"4841_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3(2):133\u2013146. https:\/\/doi.org\/10.1038\/nri1001","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4841_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/intimm\/dxh034","volume":"16","author":"WR Park","year":"2004","unstructured":"Park WR, Nakahira M, Sugimoto N, Bian Y, Yashiro-Ohtani Y, Zhou XY, Yang YF, Hamaoka T, Fujiwara H (2004) A mechanism underlying STAT4-mediated up-regulation of IFN-gamma induction inTCR-triggered T cells. Int Immunol 16(2):295\u2013302. https:\/\/doi.org\/10.1093\/intimm\/dxh034","journal-title":"Int Immunol"},{"key":"4841_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.immunol.16.1.495","volume":"16","author":"MK Gately","year":"1998","unstructured":"Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, Presky DH (1998) The interleukin-12\/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 16:495\u2013521. https:\/\/doi.org\/10.1146\/annurev.immunol.16.1.495","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"4841_CR23","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1046\/j.1523-1747.1999.00754.x","volume":"113","author":"H Kokuba","year":"1999","unstructured":"Kokuba H, Aurelian L, Burnett J (1999) Herpes simplex virus associated erythema multiforme (HAEM) is mechanistically distinct from drug-induced erythema multiforme: interferon-gamma is expressed in HAEM lesions and tumor necrosis factor-alpha in drug-induced erythema multiforme lesions. J Invest Dermatology 113(5):808\u2013815. https:\/\/doi.org\/10.1046\/j.1523-1747.1999.00754.x","journal-title":"J Invest Dermatology"},{"issue":"6","key":"4841_CR24","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"I Ivanov","year":"2006","unstructured":"Ivanov I, McKenzie B, Zhou L, Tadokoro C, Lepelley A, Lafaille J, Cua D, Littman D (2006) The orphan nuclear receptor ROR\u03b3t directs the differentiation program of Proinflammatory IL-17\u2009+\u2009T helper cells. Cell 126(6):1121\u20131133. https:\/\/doi.org\/10.1016\/j.cell.2006.07.035","journal-title":"Cell"},{"issue":"3","key":"4841_CR25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/eji.200839050","volume":"39","author":"F Annunziato","year":"2009","unstructured":"Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S (2009) Human Th17 cells: are they different from murine Th17 cells? Eur J Immunol 39(3):637\u2013640. https:\/\/doi.org\/10.1002\/eji.200839050","journal-title":"Eur J Immunol"},{"issue":"1","key":"4841_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.immuni.2008.11.005","volume":"30","author":"Y Lee","year":"2009","unstructured":"Lee Y, Turner H, Maynard C, Oliver J, Chen D, Elson C, Weaver C (2009) Late developmental plasticity in the T helper 17 lineage. Immunity 30(1):92\u2013107. https:\/\/doi.org\/10.1016\/j.immuni.2008.11.005","journal-title":"Immunity"},{"issue":"10","key":"4841_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrg3051","volume":"12","author":"ZE Sauna","year":"2011","unstructured":"Sauna ZE, Kimchi-Sarfaty C (2011) Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 12(10):683\u2013691. https:\/\/doi.org\/10.1038\/nrg3051","journal-title":"Nat Rev Genet"},{"issue":"3","key":"4841_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41557-022-01091-z","volume":"15","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Neti SS, Sitarik I, Pradhan P, To P, Xia Y, Fried SD, Booker SJ, O\u2019Brien EP (2023) How synonymous mutations alter enzyme structure and function over long timescales. Nat Chem 15(3):308\u2013318. https:\/\/doi.org\/10.1038\/s41557-022-01091-z","journal-title":"Nat Chem"},{"issue":"9","key":"4841_CR29","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00439-017-1809-4","volume":"136","author":"R Vaz-Drago","year":"2017","unstructured":"Vaz-Drago R, Custodio N, Carmo-Fonseca M (2017) Deep intronic mutations and human disease. Hum Genet 136(9):1093\u20131111. https:\/\/doi.org\/10.1007\/s00439-017-1809-4","journal-title":"Hum Genet"},{"issue":"D1","key":"4841_CR30","doi-asserted-by":"publisher","first-page":"D1243","DOI":"10.1093\/nar\/gkae974","volume":"53","author":"G Perez","year":"2025","unstructured":"Perez G, Barber GP, Benet-Pages A, Casper J, Clawson H, Diekhans M, Fischer C, Gonzalez JN, Hinrichs AS, Lee CM (2025) The UCSC genome browser database: 2025 update. Nucleic Acids Res 53(D1):D1243\u2013D1249. https:\/\/doi.org\/10.1093\/nar\/gkae974","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"4841_CR31","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2009.06.001","volume":"137","author":"JE Phillips","year":"2009","unstructured":"Phillips JE, Corces VG (2009) CTCF: master weaver of the genome. Cell 137(7):1194\u20131211. https:\/\/doi.org\/10.1016\/j.cell.2009.06.001","journal-title":"Cell"},{"issue":"1","key":"4841_CR32","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/s41467-018-03828-2","volume":"9","author":"YA Guo","year":"2018","unstructured":"Guo YA, Chang MM, Huang W, Ooi WF, Xing M, Tan P, Skanderup AJ (2018) Mutation hotspots at CTCF binding sites coupled to chromosomal instability in Gastrointestinal cancers. Nat Commun 9(1):1520. https:\/\/doi.org\/10.1038\/s41467-018-03828-2","journal-title":"Nat Commun"},{"key":"4841_CR33","doi-asserted-by":"publisher","unstructured":"Kloypan C, Koomdee N, Satapornpong P, Tempark T, Biswas M, Sukasem C (2021) A comprehensive review of HLA and severe cutaneous adverse drug reactions: implication for clinical pharmacogenomics and precision medicine. Pharmaceuticals (Basel) 14(11). https:\/\/doi.org\/10.3390\/ph14111077","DOI":"10.3390\/ph14111077"},{"issue":"3","key":"4841_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s10038-022-01040-1","volume":"68","author":"T Mushiroda","year":"2023","unstructured":"Mushiroda T (2023) Avoidance of cutaneous adverse drug reactions induced by antiepileptic drugs based on pharmacogenomics. J Hum Genet 68(3):227\u2013230. https:\/\/doi.org\/10.1038\/s10038-022-01040-1","journal-title":"J Hum Genet"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-025-04841-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-025-04841-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T18:13:54Z","timestamp":1764180834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-025-04841-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4841"],"URL":"https:\/\/doi.org\/10.1007\/s00280-025-04841-1","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Institutional Review Board of the Showa Medical University. The study was registered with the University Hospital Medical Information Network-Clinical Trials Registry for Japan on May 12, 2014 (UMIN000013939), when 6 months after approval by the Institutional Review Board of Showa Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All the patients provided written informed consent for the use of their peripheral blood samples and medical information for research purposes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All patients gave written informed consent regarding publishing their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"113"}}